Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

45 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Completed

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)

NCT01908829

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Genova Clinical Research Tucson, Arizona, United States
  • Associated Pharmaceutical Research Center, Inc. Buena Park, California, United States
  • The American Institute of Research Los Angeles, California, United States
  • Bayview Research Group Valley Village, California, United States
View all 219 locations
View Trial Details
Completed

A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice

NCT02320773

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Site CZ42009 UROMEDA s. r. o. Brno, Czechia
  • Site CZ42003 Fakultni nemocnice Brno-Bohunice Brno, Czechia
  • Site CZ42006 Hospital Kyjov Kyjov, Czechia
  • Site CZ42002 Fakultni nemocnice Kralovske Vinohrady Prague, Czechia
View all 60 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder

NCT01340027

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • BY37101 Minsk, Belarus
  • BY37102 Minsk, Belarus
  • BY37103 Minsk, Belarus
  • BY37104 Vitebsk, Belarus
View all 133 locations
View Trial Details
Completed

A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)

NCT02386072

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Site US1051 Birmingham, Alabama, United States
  • Site US1094 Birmingham, Alabama, United States
  • Site US1010 Huntsville, Alabama, United States
  • Site US1020 Mobile, Alabama, United States
View all 92 locations
View Trial Details
Completed

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

NCT04200963

Conditions
Advanced Cancer, Advanced Solid Tumor, Bladder Cancer, +35 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment

NCT00210249

Conditions
Adnexal Diseases, Bladder Disease, Digestive System Diseases, +25 more
Locations
  • Centre de radiothérapie d'Agen Agen, France
  • Centre Hospitalier Universitaire d'Agen Agen, France
  • Clinique Esquirol Saint Hilaire Agen, France
  • Centre Hospitalier Universitaire de Bayonne Bayonne, France
View all 18 locations
View Trial Details

Related conditions